Nociplastic Pain: Difference between revisions
From WikiMSK
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==Epidemiology== | ==Epidemiology== | ||
The prevalence of chronic pain in New Zealand was measured at 16.9% in 2011{{#pmid:21946879|name}} | The prevalence of chronic pain in New Zealand, when defined as lasting for 6 months or longer, was measured at 16.9% in 2011. Prevalence increased with age and economic deprivation. Pacific and Asian peoples had lower rates of chronic pain than European/other.{{#pmid:21946879|name}} Around one fifth of people with chronic pain have predominantly neuropathic pain.{{cite}} Neuropathic pain is more disabling than other forms of pain and is associated with a lower quality of life.{{cite}} | ||
==Definitions== | |||
The IASP definition of pain was recently updated in 2019. | |||
{{quote|An aversive sensory and emotional experience typically caused by, or resembling that caused by, actual or potential tissue injury|IASP Definition of Pain 2019}} | |||
==Key Articles== | ==Key Articles== |
Revision as of 18:16, 27 July 2020
Epidemiology
The prevalence of chronic pain in New Zealand, when defined as lasting for 6 months or longer, was measured at 16.9% in 2011. Prevalence increased with age and economic deprivation. Pacific and Asian peoples had lower rates of chronic pain than European/other.[1] Around one fifth of people with chronic pain have predominantly neuropathic pain.[citation needed] Neuropathic pain is more disabling than other forms of pain and is associated with a lower quality of life.[citation needed]
Definitions
The IASP definition of pain was recently updated in 2019.
“An aversive sensory and emotional experience typically caused by, or resembling that caused by, actual or potential tissue injury”
—IASP Definition of Pain 2019
Key Articles
- {{#l:Cohen2016 - nociplastic pain third mechanistic descriptor.pdf}}
- {{#l:Woolf2011 - Central sensitisation.pdf}}
- {{#l:Woolf2014 - Nociceptive amplification naming.pdf}}
- {{#l:Yunus2008 - Central sensitivity syndrome.pdf}}